Janux Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Janux Therapeutics Inc
TickerJANX
CIK #0001817713
CUSIP47103J105
SectorLife Sciences - Pharmaceutical Preparations
Address11099 Torrey Pines Park Road, San Diego, CA 92037
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Janux Therapeutics Inc 2021-04-30 125.0 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001817713] 10-K
[0001817713] 10-Q
[0001817713] 3
[0001817713] 4
[0001817713] 8-K
[0001817713] D
[0001817713] SC 13D
[0001817713] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
State Street Corp Janux Therapeutics Inc [2026-05-12] 0.0
Point72 Asset Management LP Janux Therapeutics Inc [2026-04-29] 0.0
Point72 Asset Management LP Janux Therapeutics Inc [2026-04-29] 0.0
State Street Corp Janux Therapeutics Inc [2026-02-09] 0.0
ProSight Management LP Janux Therapeutics Inc [2026-02-06] 0.0
BlackRock Inc Janux Therapeutics Inc [2025-07-17] 0.0
Janus Henderson Group PLC Janux Therapeutics Inc [2025-02-14] 0.0
Adage Capital Management LP Janux Therapeutics Inc [2025-02-12] 0.0
Paradigm Biocapital Advisors LP Janux Therapeutics Inc [2024-10-23] 5.0
Citadel Advisors LLC Janux Therapeutics Inc [2023-07-10] 4.9
Biotechnology Value Fund L P Janux Therapeutics Inc [2023-05-30] 5.2
EcoR1 Capital LLC Janux Therapeutics Inc [2023-01-23] 7.8
Janus Henderson Group PLC Janux Therapeutics Inc [2022-02-14] 5.8
Campbell David Alan Janux Therapeutics Inc [2022-02-11] 5.0
FMR LLC Janux Therapeutics Inc [2022-01-10] 0.0
Avalon Ventures Xi LP Janux Therapeutics Inc [2021-06-25] 11.0
Bregua Corp Janux Therapeutics Inc [2021-06-25] 9.0
OrbiMed Advisors LLC Janux Therapeutics Inc [2021-06-22] 7.3
RA Capital Management LP Janux Therapeutics Inc [2021-06-16] 20.8
Form 3/4/5 Filer 2011 - 2026
Janux Therapeutics Inc
Capps Vickie L
Dobmeier Eric
Simson Jake
Hernday Natasha
Kung Winston
Shah Rajeev M
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II LP
RA Capital Management LP
Kolchinsky Peter
Barrett Ronald W
Doyle Janeen Noel
Dobek Maria
Go William
Campbell David Alan
DiRaimondo Thomas
Winter Charles M
Meyer Andrew Hollman
McIver Zachariah
Gujrathi Sheila
McNulty Alana B
Robinson Byron
Lichter Jay
Avalon BioVentures SPV I LP
Avalon Ventures XI LP
Avalon BioVentures I LP
Reardon Tighe
Godfrey Wayne
Thompson Peter A
Heller Stefan
Salek-Ardakani Shahram
OrbiMed Advisors LLC
OrbiMed Capital GP VIII LLC
OrbiMed Genesis GP LLC
OrbiMed Capital GP VII LLC
Bregua Corp
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Go William
Common Stock
2026-02-02 Grant 44,000 $0.00
Go William
Stock option (right to buy) · derivative
2026-02-02 Grant 154,000 $0.00
DiRaimondo Thomas
Common Stock
2026-01-02 Sell 2,505 $13.73 34,394
Campbell David Alan
Common Stock
2026-01-02 Sell 8,072 $13.73 110,829
Campbell David Alan
Common Stock
2026-01-02 Grant 96,600 $0.00
Winter Charles M
Common Stock
2026-01-02 Grant 28,600 $0.00
Winter Charles M
Common Stock
2026-01-02 Sell 2,401 $13.73 32,966
McIver Zachariah
Common Stock
2026-01-02 Grant 29,000 $0.00
McIver Zachariah
Common Stock
2026-01-02 Sell 2,714 $13.73 37,263
Doyle Janeen Noel
Common Stock
2026-01-02 Grant 36,000 $0.00
Dobek Maria
Common Stock
2026-01-02 Grant 18,935 $0.00
Dobek Maria
Common Stock
2026-01-02 Sell 1,462 $13.73 20,073
DiRaimondo Thomas
Stock option (right to buy) · derivative
2026-01-02 Grant 109,900 $0.00
Campbell David Alan
Stock option (right to buy) · derivative
2026-01-02 Grant 338,100 $0.00
Winter Charles M
Stock option (right to buy) · derivative
2026-01-02 Grant 100,100 $0.00
McIver Zachariah
Stock option (right to buy) · derivative
2026-01-02 Grant 101,500 $0.00
Doyle Janeen Noel
Stock option (right to buy) · derivative
2026-01-02 Grant 126,000 $0.00
Dobek Maria
Stock option (right to buy) · derivative
2026-01-02 Grant 42,600 $0.00
Meyer Andrew Hollman
Common Stock
2026-01-02 Sell 1,879 $13.73 25,799
DiRaimondo Thomas
Common Stock
2026-01-02 Grant 31,400 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 192 59,609,065
2025-12-31 180 62,582,739
2025-09-30 175 63,898,016
2025-06-30 175 65,341,262
2025-03-31 186 65,827,535
2024-12-31 220 62,710,663
2024-09-30 163 46,208,479
2024-06-30 157 46,130,690
2024-03-31 123 43,386,030
2023-12-31 66 33,603,508
2023-09-30 59 35,125,253
2023-06-30 55 30,527,155
Form 13F Holdings
Firm Period DFND Voting Shares
Y-Intercept Hong Kong Ltd [2026-06-30] SOLE 196,487 196,487
Congress Asset Management Co [2026-06-30] SOLE 59,210 67,610
TEMA ETFS LLC [2026-06-30] SOLE 51,522 51,522
Diversified Trust Co [2026-06-30] SOLE 0 16,841
Versant Capital Management Inc [2026-06-30] SOLE 2,615 2,615
Gamma Investing LLC [2026-06-30] DFND 981 981
Fortitude Family Office LLC [2026-06-30] SOLE 239 239
Farther Finance Advisors LLC [2026-06-30] SOLE 0 163
BFSG LLC [2026-06-30] SOLE 0 100
Aventura Private Wealth LLC [2026-06-30] SOLE 88 88
LRI Investments LLC [2026-06-30] SOLE 41 41
FNY Investment Advisers LLC [2026-06-30] SOLE 30,850 30
Ares Financial Consulting LLC [2026-06-30] SOLE 25 25
Capital Advisors Ltd LLC [2026-06-30] SOLE 0 8
IFP Advisors LLC [2026-06-30] SOLE 1 1
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com